Following 16 months of construction, Vetter has completed the first phase of a new multi-functional building at the company’s Ravensburg Schuetzenstrasse site in Germany. The new facility is expected to to be fully operational by the beginning of 2016 and will contain laboratories and workplaces for Vetter Development Service as well as a secure data center and additional office space for a total area of 8,500 square meters. The EUR 26 million ($29 million) investment is due to increased customer demand drug development and for enhancing company-wide IT systems.

Vetter Development Service provides services in support in clinical drug development, including pharmaceutical analysis, process development, and clinical trial supply. In addition to the Ravensburg facility, the company offers such services at its facility in Chicago, Illinois.

The six-story building will contain laboratory space for performing microbiological analysis and will also have spare capacity to meet future growth needs such as additional cleanrooms and labs. The new data center will have enhanced security systems and a safety cell that protects technology and data from external physical hazards, as well as a gas extinguishing system to minimize damage in the event of an emergency.

Source: Vetter